Literature DB >> 23458207

The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients.

Chieh Suai Tan1, Cui Jie, Jennifer Joe, Zubin D Irani, Suvranu Ganguli, Sanjeeva Prasad Kalva, Stephan Wicky, Steven Wu.   

Abstract

Creating a vascular access in the presence of a cardiovascular implantable electronic device (CIED) in a patient with or approaching end-stage renal disease can be challenging. In this study, we aimed to evaluate the impact of a CIED on the outcomes of vascular access creation in hemodialysis patients and determine their effects on vascular access patency. This is a single-center retrospective review of hemodialysis patients who underwent vascular access creation after CIED placement. Outcomes of vascular access creation and need for endovascular interventions were compared between patients with vascular access created ipsilateral and contralateral to the site of CIED. Comparing patients with arteriovenous (AV) access created ipsilateral to CIED placement (n=19) versus the contralateral side (n=17), the primary failure rate was 78.9% versus 35.3% (p=0.02). For AV accesses that were matured, the median primary patency durations for AV accesses created ipsilateral to the CIED was 11.2 months compared to 7.8 months for AV accesses created contralateral to the CIED (p=1.00). AV accesses created ipsilateral to a CIED have a higher primary failure rate compared with the contralateral arm and should be avoided as much as possible.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23458207     DOI: 10.1111/sdi.12073

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

1.  Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.

Authors:  Anamika Adwaney; Charlotte Lim; Sarah Blakey; Neill Duncan; Damien R Ashby
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-14       Impact factor: 8.237

2.  Iatrogenic Infective Endocarditis in Hemodialysis Patients: A Case Report and Review of the Literature.

Authors:  Ali Oullaï; Edouard Cubilier; Mohamed Tayeb Salaouatchi; Maxime Taghavi; Yasmin Zouggari; Joëlle Nortier; Maria Do Carmo Filomena Mesquita
Journal:  Case Rep Nephrol       Date:  2022-06-29

3.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

4.  Hemodialysis Tunneled Catheter Noninfectious Complications.

Authors:  Lisa M Miller; Jennifer M MacRae; Mercedeh Kiaii; Edward Clark; Christine Dipchand; Joanne Kappel; Charmaine Lok; Rick Luscombe; Louise Moist; Matthew Oliver; Pamela Pike; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

5.  Arteriovenous Access Failure, Stenosis, and Thrombosis.

Authors:  Jennifer M MacRae; Christine Dipchand; Matthew Oliver; Louise Moist; Charmaine Lok; Edward Clark; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Rick Luscombe; Lisa M Miller
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

6.  Severity and Extent of Lead-Related Venous Obstruction in More Than 3000 Patients Undergoing Transvenous Lead Extraction.

Authors:  Marek Czajkowski; Wojciech Jacheć; Anna Polewczyk; Jarosław Kosior; Dorota Nowosielecka; Łukasz Tułecki; Paweł Stefańczyk; Andrzej Kutarski
Journal:  Vasc Health Risk Manag       Date:  2022-08-17

7.  Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study.

Authors:  Seonjeong Jeong; Gi Byoung Nam; Jai Won Chang; Min-Ju Kim; Youngjin Han; Tae-Won Kwon; Yong-Pil Cho
Journal:  BMC Nephrol       Date:  2018-10-20       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.